FDA Investigator

Nancy M Espinal

Latest inspection on record: Saclay, France, December 2022 · records back to 2015

Human DrugsAnimal Drugs & FeedsFoods & CosmeticsMedical Devices & Rad Health

FDA inspection record · Last updated July 12, 2026

Overview

  • 68 inspections across 57 sites are on record.
  • 205 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2022-12-16.

At a glance

Inspections

68

Sites

57

Observations

205

Career since

Oct 2015

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Cis Bio International16 Dec 2022Human DrugsView 483 →
Cenexi - Laboratoires Thissen Sa6 Dec 2022Human DrugsView 483 →
DR.REDDY'S LABORATORIES LIMITED29 Oct 2021Human DrugsView 483 →
Symed Labs Limited16 Oct 2021Human DrugsOn file
Lupin Limited18 Sep 2021Human DrugsOn file

Sites inspected

Cis Bio InternationalSaclay, France1 insp.
Cenexi - Laboratoires Thissen SaBraine-l'Alleud, Belgium1 insp.
DR.REDDY'S LABORATORIES LIMITEDVisakhapatnam, India1 insp.
Symed Labs LimitedChoutuppal, India1 insp.
Lupin LimitedVerna, India1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Nancy M Espinal's 205 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site